000 | 01438 a2200397 4500 | ||
---|---|---|---|
005 | 20250511175743.0 | ||
264 | 0 | _c19931018 | |
008 | 199310s 0 0 eng d | ||
022 | _a0077-8923 | ||
024 | 7 |
_a10.1111/j.1749-6632.1992.tb51641.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSeifried, E | |
245 | 0 | 0 |
_aBolus application of a novel recombinant plasminogen activator in acute myocardial infarction patients: pharmacokinetics and effects on the hemostatic system. _h[electronic resource] |
260 |
_bAnnals of the New York Academy of Sciences _cDec 1992 |
||
300 |
_a417-20 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aHemostatics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyocardial Infarction _xblood |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
700 | 1 | _aMüller, M M | |
700 | 1 | _aMartin, U | |
700 | 1 | _aKönig, R | |
700 | 1 | _aHombach, V | |
773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 667 _gp. 417-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.1992.tb51641.x _zAvailable from publisher's website |
999 |
_c1315585 _d1315585 |